Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders

Medical Hypotheses

Volumn 65, Issue 5, 2005, Pages 953-955

  Yamagishi, S ^a   Nakamura, K ^a   Inoue, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PLANT EXTRACT; PROBIOTIC AGENT;

AGING; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CHLORELLA; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; GLYCATION; GREEN ALGA; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ARTERIOSCLEROSIS; CHEMISTRY; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION;

ANIMALIA; CHLORELLA (CHLORELLALES); CHLORELLA (PRASIOLALES); CHLORELLA (UNCLASSIFIED CHLOROPHYCEAE); CHLORELLA (UNCLASSIFIED TREBOUXIOPHYCEAE); CHLOROPHYTA;

ADMINISTRATION, ORAL; ANIMALS; ARTERIOSCLEROSIS; CHLORELLA; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PROBIOTICS;

EID: 27244443902     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.05.006     Document Type: Article

References (13)

1. M. Brownlee Advanced protein glycosylation in diabetes and aging Ann Rev Med 46 1995 223 234
2. S.K. Grandhee, and V.M. Monnier Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors J Biol Chem 266 1991 11649 11653
3. S. Yamagishi, M. Takeuchi, Y. Inagaki, K. Nakamura, and T. Imaizumi Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy Int J Clin Pharmacol Res 23 2003 129 134
4. H. Vlassara, R. Bucala, and L. Striker Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab Invest 70 1994 138 151
5. A. Bierhaus, M.A. Hofmann, R. Ziegler, and P.P. Nawroth AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc Res 7 1998 586 600
6. A.M. Schmidt, and D. Stern Atherosclerosis and diabetes: the RAGE connection Curr Atheroscler Rep 2 2000 430 436
7. T. Nishikawa, D. Edelstein, and X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
8. R. Abe, T. Shimizu, and H. Sugawara Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions J Invest Dermatol 122 2004 461 476
9. M. Takeuchi, S. Kikuchi, and N. Sasaki Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease Curr Alzheimer Res 1 2004 39 46
10. T. Sano, and Y. Tanaka Effect of dried, powered Chlorella vulgaris on experimental atherosclerosis and alimentary hypercholesterolemia in cholesterol-fed rabbits Artery 14 1987 76 84
11. H.S. Lee, C.Y. Choi, C. Cho, and Y. Song Attenuating effect of Chlorella supplement on oxidative stress and NF-kB activation in peritoneal macrophage and liver of C57BL/6 mice fed on an atherogenic diet Biosci Biotechnol Biochem 67 2003 2083 2090
12. K. Yaukawa, T. Akihisa, and H. Kanno Inhibitory effect of sterols isolated form Chlorella vulgaris on 12-O-tetradecanolylphorbol-13-acetate- induced inflammation and tumor progression Biol Pharm Bull 19 1996 573 576
13. S. Guzman, A. Gato, and J.M. Calleja Anti-imflammatory activities of the marine microalgae Chlorella stigmatophora and Phaeodactylum tricornutum Phytother Res 15 2001 224 230